Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Changes in Stockholders??? Equity

v3.22.4
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
Common Stock
Additional Paid in Capital
Accumulated Deficits
Accumulated Other Comprehensive Income (Loss)
Total
Balance at Dec. 31, 2020 $ 9,488 $ 73,160,616 $ (32,383,833) $ (1,754,228) $ 39,032,043
Balance (in Shares) at Dec. 31, 2020 9,487,889        
Stock compensation expense 1,680,365 1,680,365
Revaluation of stock warrant (355,600) (355,600)
Other comprehensive income (loss) 393,767 393,767
Net loss for the period (4,228,126)   (4,228,126)
Balance at Mar. 31, 2021 $ 9,488 74,485,381 (36,611,959) (1,360,461) 36,522,449
Balance (in Shares) at Mar. 31, 2021 9,487,889        
Balance at Dec. 31, 2020 $ 9,488 73,160,616 (32,383,833) (1,754,228) 39,032,043
Balance (in Shares) at Dec. 31, 2020 9,487,889        
Net loss for the period         (4,062,713)
Balance at Sep. 30, 2021 $ 9,488 74,763,077 (36,446,546) (1,914,936) 36,411,083
Balance (in Shares) at Sep. 30, 2021 9,487,889        
Balance at Mar. 31, 2021 $ 9,488 74,485,381 (36,611,959) (1,360,461) 36,522,449
Balance (in Shares) at Mar. 31, 2021 9,487,889        
Stock compensation expense 179,331 179,331
Revaluation of stock warrant (42,000) (42,000)
Other comprehensive income (loss) (524,181) (524,181)
Net loss for the period (1,535,901) (1,535,901)
Balance at Jun. 30, 2021 $ 9,488 74,622,712 (38,147,860) (1,884,642) 34,599,698
Balance (in Shares) at Jun. 30, 2021 9,487,889        
Stock compensation expense 161,465 161,465
Revaluation of stock warrant (21,100) (21,100)
Other comprehensive income (loss) (30,294) (30,294)
Net loss for the period 1,701,314 1,701,314
Balance at Sep. 30, 2021 $ 9,488 74,763,077 (36,446,546) (1,914,936) 36,411,083
Balance (in Shares) at Sep. 30, 2021 9,487,889        
Balance at Dec. 31, 2021 $ 9,716 77,825,976 (41,767,258) (1,896,158) 34,172,276
Balance (in Shares) at Dec. 31, 2021 9,715,889        
Stock compensation expense 246,999 246,999
Other comprehensive income (loss) 518,027 518,027
Net loss for the period (2,479,213) (2,479,213)
Balance at Mar. 31, 2022 $ 9,716 78,072,975 (44,246,471) (1,378,131) 32,458,089
Balance (in Shares) at Mar. 31, 2022 9,715,889        
Balance at Dec. 31, 2021 $ 9,716 77,825,976 (41,767,258) (1,896,158) 34,172,276
Balance (in Shares) at Dec. 31, 2021 9,715,889        
Net loss for the period         (9,020,680)
Balance at Sep. 30, 2022 $ 9,720 78,878,066 (50,787,938) 585,845 28,685,693
Balance (in Shares) at Sep. 30, 2022 9,720,003        
Balance at Mar. 31, 2022 $ 9,716 78,072,975 (44,246,471) (1,378,131) 32,458,089
Balance (in Shares) at Mar. 31, 2022 9,715,889        
Issuance of common stock $ 4 32,908 32,912
Issuance of common stock (in Shares) 4,114        
Stock compensation expense 712,341 712,341
Other comprehensive income (loss) 673,064 673,064
Net loss for the period (2,734,928) (2,734,928)
Balance at Jun. 30, 2022 $ 9,720 78,818,224 (46,981,399) (705,067) 31,141,478
Balance (in Shares) at Jun. 30, 2022 9,720,003        
Issuance of common stock
Stock compensation expense 59,842 59,842
Other comprehensive income (loss) 1,290,912 1,290,912
Net loss for the period (3,806,539) (3,806,539)
Balance at Sep. 30, 2022 $ 9,720 $ 78,878,066 $ (50,787,938) $ 585,845 $ 28,685,693
Balance (in Shares) at Sep. 30, 2022 9,720,003